17-31229155-T-G
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001042492.3(NF1):c.2540T>G(p.Leu847Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L847P) has been classified as Pathogenic.
Frequency
Consequence
NM_001042492.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:4
Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000573019). The variant has been observed in multiple (>3) similarly affected unrelated individuals (PMID: 29290338, 26478990, 27999334, 25325900). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000068323, PMID:10712197). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.856>=0.6, 3CNET: 0.997>=0.75). It is not observed in the gnomAD v2.1.1 dataset. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
This sequence change replaces leucine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 847 of the NF1 protein (p.Leu847Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with neurofibromatosis type 1 (PMID: 25325900, 26478990, 27999334, 29290338). ClinVar contains an entry for this variant (Variation ID: 573019). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt NF1 protein function with a positive predictive value of 95%. This variant disrupts the p.Leu847 amino acid residue in NF1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10712197, 10862084, 12552569, 15146469, 23668869, 24413922). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
- -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The p.L847R pathogenic mutation (also known as c.2540T>G), located in coding exon 21 of the NF1 gene, results from a T to G substitution at nucleotide position 2540. The leucine at codon 847 is replaced by arginine, an amino acid with dissimilar properties. This alteration has been observed in multiple individuals with a personal and/or family history that is consistent with NF1-related disease (van Minkelen R et al. Clin Genet, 2014 Apr;85:318-27; Maruoka R et al. Genet Test Mol Biomarkers, 2014 Nov;18:722-35; Esposito T et al. J Neurochem, 2015 Dec;135:1123-8; Cunha KS et al. Genes (Basel), 2016 Dec;7; Koczkowska M et al. Am J Hum Genet, 2018 Jan;102:69-87; Giugliano T et al. Genes (Basel), 2019 Jul;10; Napolitano F et al. Genes (Basel), 2022 Jun;13). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at